{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:46:07Z","timestamp":1791841567931,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2023ZD0503905"],"award-info":[{"award-number":["2023ZD0503905"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cjca.2026.05.011","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:14:28Z","timestamp":1779750868000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Left Ventricular Ejection Fraction on Outcomes With Drug-coated Balloons vs Drug-Eluting Stents for De Novo Coronary Artery Disease"],"prefix":"10.1016","author":[{"given":"Bo","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangyu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhe","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjun","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duolao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2026.05.011_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41569-019-0234-x","article-title":"Drug-eluting coronary stents: insights from preclinical and pathology studies","volume":"17","author":"Torii","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2026.05.011_bib2","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.05.011_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jacc.2019.12.046","article-title":"Drug-coated balloon for de novo coronary artery disease: JACC State-of-the-Art Review","volume":"75","author":"Yerasi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2026.05.011_bib4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.05.011_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.05.011_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","article-title":"Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis","volume":"110","author":"Scheller","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.05.011_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2025.10.027","article-title":"Drug-coated balloon angioplasty vs up-front stenting for de novo CAD: 3-year follow-up of REC-CAGEFREE I trial","volume":"87","author":"Tao","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2026.05.011_bib8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0002-9149(03)00261-3","article-title":"Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions <or=40%, 41% to 49%, and >or=50% having percutaneous coronary revascularization","volume":"91","author":"Keelan","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2026.05.011_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.amjcard.2011.09.016","article-title":"Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction","volume":"109","author":"Sardi","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2026.05.011_bib10","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1093\/eurheartj\/ehu303","article-title":"Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society","volume":"35","author":"Mamas","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.05.011_bib11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCRESAHA.113.302254","article-title":"Research advances in heart failure: a compendium","volume":"113","author":"Braunwald","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2026.05.011_bib12","first-page":"Cd003333","article-title":"Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm","volume":"9","author":"Shantsila","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2026.05.011_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.thromres.2020.08.041","article-title":"Association of fractalkine with functional severity of heart failure and impact on clopidogrel efficacy in patients with ischemic heart disease","volume":"196","author":"Marcano","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2026.05.011_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12872-024-03709-1","article-title":"Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjca.2026.05.011_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082945","article-title":"Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trial","volume":"388","author":"Gao","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2026.05.011_bib16","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0140-6736(24)01594-0","article-title":"Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial","volume":"404","author":"Gao","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.05.011_bib17","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2026.05.011_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcmg.2015.02.014","article-title":"Ethnic-specific normative reference values for echocardiographic LA and LV size, LV mass, and systolic function: the EchoNoRMAL study","volume":"8","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2026.05.011_bib19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCULATIONAHA.122.063642","article-title":"Clinical characteristics and outcomes in patients with heart failure: are there thresholds and inflection points in left ventricular ejection fraction and thresholds justifying a clinical classification?","volume":"148","author":"Kondo","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.05.011_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.2023.11887","article-title":"Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial","volume":"330","author":"Neilan","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2026.05.011_bib21","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/eurheartj\/ehz453","article-title":"Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial","volume":"40","author":"Serruys","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.05.011_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00392-013-0609-7","article-title":"Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group","volume":"102","author":"Kleber","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjca.2026.05.011_bib23","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the International DCB Consensus Group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2026.05.011_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.05.011_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2012.08.040","article-title":"Comparison of three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus \u2265 40% (from the HORIZONS-AMI trial)","volume":"111","author":"Daneault","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2026.05.011_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjcard.2005.03.069","article-title":"Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction","volume":"96","author":"Halkin","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2026.05.011_bib27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2026.05.011_bib28","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"L\u00fcscher","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.05.011_bib29","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/0735-1097(93)90787-2","volume":"22","author":"Appleton","year":"1993","journal-title":"J Am Coll Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26005076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26005076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:03:52Z","timestamp":1791839032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X26005076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S0828282X26005076"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2026.05.011","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Left Ventricular Ejection Fraction on Outcomes With Drug-coated Balloons vs Drug-Eluting Stents for De Novo Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2026.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}